PDS5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.079200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.771800E-01
Normal-vs-Stage2
4.806200E-01
Normal-vs-Stage3
3.994400E-02
Normal-vs-Stage4
9.152600E-01
Stage1-vs-Stage2
7.844200E-01
Stage1-vs-Stage3
2.985600E-02
Stage1-vs-Stage4
3.067400E-01
Stage2-vs-Stage3
5.571700E-02
Stage2-vs-Stage4
3.210800E-01
Stage3-vs-Stage4
7.340100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.920400E-01
Normal-vs-AfricanAmerican
9.528600E-01
Normal-vs-Asian
2.411800E-01
Caucasian-vs-AfricanAmerican
2.842200E-01
Caucasian-vs-Asian
2.795600E-01
AfricanAmerican-vs-Asian
1.665010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.813800E-01
Normal-vs-Female
5.600000E-01
Male-vs-Female
5.651200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.491400E-01
Normal-vs-Age(41-60Yrs)
9.441000E-01
Normal-vs-Age(61-80Yrs)
3.715600E-01
Normal-vs-Age(81-100Yrs)
2.238000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.587000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.472800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.614400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.099300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.234300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.888200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.818000E-01
Normal-vs-Daily Drinker
1.763360E-01
Normal-vs-Weekly Drinker
3.526400E-01
Normal-vs-Occasional Drinker
7.691800E-01
Normal-vs-Social Drinker
6.863000E-01
Non Drinker-vs-Daily Drinker
5.133200E-01
Non Drinker-vs-Weekly Drinker
9.260000E-01
Non Drinker-vs-Occasional Drinker
1.915570E-01
Non Drinker-vs-Social Drinker
4.237600E-01
Daily Drinker-vs-Weekly Drinker
4.798800E-01
Daily Drinker-vs-Occasional Drinker
4.513500E-02
Daily Drinker-vs-Social Drinker
1.697360E-01
Weekly Drinker-vs-Occasional Drinker
2.546800E-01
Weekly Drinker-vs-Social Drinker
5.173800E-01
Occasional Drinker-vs-Social Drinker
7.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.723000E-01
Normal-vs-Grade 2
7.178600E-01
Normal-vs-Grade 3
1.768600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.492000E-01
Grade 1-vs-Grade 3
7.021200E-01
Grade 1-vs-Grade 4
3.723000E-01
Grade 2-vs-Grade 3
1.000560E-01
Grade 2-vs-Grade 4
7.178600E-01
Grade 3-vs-Grade 4
1.768600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.668800E-01
Normal-vs-NonDiabetic
4.768200E-01
Diabetic-vs-NonDiabetic
2.960800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.778600E-01
Normal-vs-NoPancreatitis
4.556800E-01
Pancreatitis-vs-NoPancreatitis
9.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.919200E-01
Normal-vs-N1
5.052400E-01
N0-vs-N1
9.186800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.473600E-01
Normal-vs-TP53-NonMutant
6.448000E-01
TP53-Mutant-vs-TP53-NonMutant
3.035600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
